Oliver Uecke

Posts by Oliver

Launch of BEAt-DKD

Oliver Uecke February 6, 2017

An Innovative Medicines Initiative (IMI) Project for Precision Medicine in Diabetic Kidney Disease

with Lipotype as project partner

BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-­­year project (total budget 28.9 Million Euro) with the aim to improve prevention and management of Diabetes Kidney Disease (DKD).

read more ➔

robert_koch_medal_gold_medal_161103.jpg

Robert Koch Gold Medal 2016 to Kai Simons

Oliver Uecke November 4, 2016

Press release

Berlin/Dresden, 4 November 2016: Kai Simons, founding director of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) and managing director of Lipotype GmbH, receives the Robert Koch Medal in Gold for his lifetime achievements, in particular for his characterization of membrane-forming lipids and the development of the lipid raft concept. The Award Ceremony takes place on Friday, November 4th 2016 at the Berlin-Brandenburg Academy of Sciences and Humanities.

read more ➔

, ,

Join the lipid revolution! Lipidomics for everybody

Oliver Uecke May 10, 2016

Lipids remained in the shadow of the ongoing “omics” upheaval in biology. But this is now changing. It was never so easy for researchers from universities, research institutes and clinics to try out lipidomics. Lipotype enables researchers to integrate lipidomics in their research. Our lipid analysis start with just 150 Euros per sample, are convenient to order via webshop and deliver publication-ready results.

read more ➔

,

Lipotype GmbH and Nestlé Institute of Health Sciences collaborate on lipidomics research

Oliver Uecke October 7, 2015

Press Release, Dresden, 07th October 2015

Lipotype GmbH, a Max-Planck spin-off company and the Nestlé Institute of Health Sciences (NIHS) collaborate to employ the innovative Lipotype Shotgun Lipidomics Technology to analyse lipids in blood for nutritional research. Recently, Lipotype and NIHS jointly published results of the robustness of the Lipotype Technology. Lipotype envisions a future use of its technology in clinical diagnostics screens for establishing reliable lipid diagnostic biomarkers.

read more ➔

,

Lipotype and Nestle Institute of Health Sciences publish paper about the Lipotype shotgun lipidomics platform

Oliver Uecke October 6, 2015

An automated shotgun lipidomics platform for high throughput, comprehensive,
and quantitative analysis of blood plasma intact lipids

Blood plasma has gained protagonism in lipidomics studies due to its availability, uncomplicated collection and preparation, and informative readout of physiological status. At the same time, it is also technically challenging to analyze due to its complex lipid composition affected by many factors, which can hamper the throughput and/or lipidomics coverage.

read more ➔

,